Patent · US Active

Highly stereoselective process for preparing gemcitabine and intermediates thereof

US8324373B2 · kind B2 · utility

2Cited by
6References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 7, 2007
Grant dateDec 4, 2012
Priority date
Expiry dateAug 15, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H3/08
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides a novel and highly stereoselective process for preparing gemcitabine, which is suitable for industrial production, wherein, it includes the following reactions. Additionally, the invention discloses the key intermediates. The definition for the groups of G1, G2, G3, G4, and G5 are described in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.